Karl Proba

906 total citations
9 papers, 701 citations indexed

About

Karl Proba is a scholar working on Molecular Biology, Radiology, Nuclear Medicine and Imaging and Immunology. According to data from OpenAlex, Karl Proba has authored 9 papers receiving a total of 701 indexed citations (citations by other indexed papers that have themselves been cited), including 9 papers in Molecular Biology, 4 papers in Radiology, Nuclear Medicine and Imaging and 2 papers in Immunology. Recurrent topics in Karl Proba's work include Monoclonal and Polyclonal Antibodies Research (4 papers), Protein purification and stability (3 papers) and Glycosylation and Glycoproteins Research (2 papers). Karl Proba is often cited by papers focused on Monoclonal and Polyclonal Antibodies Research (4 papers), Protein purification and stability (3 papers) and Glycosylation and Glycoproteins Research (2 papers). Karl Proba collaborates with scholars based in Switzerland and Germany. Karl Proba's co-authors include Andreas Plückthun, Annemarie Honegger, P. Sonderegger, Georg E. Schulz, Jörg Freigang, Kay Diederichs, Lukas Leder, Wolfram Welte, Liming Ge and Talitha R. Bakker and has published in prestigious journals such as Cell, Nucleic Acids Research and Journal of Molecular Biology.

In The Last Decade

Karl Proba

9 papers receiving 680 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Karl Proba Switzerland 8 537 328 96 90 70 9 701
Florian Cymer Germany 17 889 1.7× 192 0.6× 114 1.2× 100 1.1× 79 1.1× 26 1.0k
Roberta Pascolutti United States 7 559 1.0× 287 0.9× 242 2.5× 98 1.1× 58 0.8× 8 851
Kaori Esaki Japan 8 626 1.2× 399 1.2× 18 0.2× 48 0.5× 62 0.9× 8 736
Carina Frauer Germany 8 899 1.7× 222 0.7× 56 0.6× 60 0.7× 27 0.4× 8 1.0k
Nicolas Béry France 13 762 1.4× 350 1.1× 91 0.9× 84 0.9× 22 0.3× 28 932
Detlef Grunow Germany 11 575 1.1× 116 0.4× 73 0.8× 95 1.1× 22 0.3× 18 667
Holly Prentice United States 15 743 1.4× 197 0.6× 107 1.1× 240 2.7× 25 0.4× 19 1.1k
Fabrice Cornille France 19 746 1.4× 70 0.2× 118 1.2× 110 1.2× 93 1.3× 24 1.1k
Nils B. Adey United States 16 727 1.4× 242 0.7× 146 1.5× 78 0.9× 23 0.3× 20 961
Peter C. Fridy United States 11 814 1.5× 206 0.6× 380 4.0× 87 1.0× 22 0.3× 18 1.1k

Countries citing papers authored by Karl Proba

Since Specialization
Citations

This map shows the geographic impact of Karl Proba's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Karl Proba with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Karl Proba more than expected).

Fields of papers citing papers by Karl Proba

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Karl Proba. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Karl Proba. The network helps show where Karl Proba may publish in the future.

Co-authorship network of co-authors of Karl Proba

This figure shows the co-authorship network connecting the top 25 collaborators of Karl Proba. A scholar is included among the top collaborators of Karl Proba based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Karl Proba. Karl Proba is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

9 of 9 papers shown
1.
Binz, Hans, Talitha R. Bakker, Douglas J. Phillips, et al.. (2017). Design and characterization of MP0250, a tri-specific anti-HGF/anti-VEGF DARPin® drug candidate. mAbs. 9(8). 1262–1269. 51 indexed citations
2.
Freigang, Jörg, Karl Proba, Lukas Leder, et al.. (2000). The Crystal Structure of the Ligand Binding Module of Axonin-1/TAG-1 Suggests a Zipper Mechanism for Neural Cell Adhesion. Cell. 101(4). 425–433. 141 indexed citations
3.
Proba, Karl, et al.. (1998). Antibody scFv fragments without disulfide bonds, made by molecular evolution. Journal of Molecular Biology. 275(2). 245–253. 204 indexed citations
4.
Proba, Karl, et al.. (1998). Cloning and sequencing of the cDNA encoding human neurotrypsin. Biochimica et Biophysica Acta (BBA) - Gene Structure and Expression. 1396(2). 143–147. 26 indexed citations
5.
Proba, Karl, Annemarie Honegger, & Andreas Plückthun. (1997). A natural antibody missing a cysteine in VH: consequences for thermodynamic stability and folding. Journal of Molecular Biology. 265(2). 161–172. 121 indexed citations
6.
Proba, Karl, et al.. (1996). Structure of a Mutant Adenylate Kinase Ligated with an ATP-analogue Showing Domain Closure Over ATP. Journal of Molecular Biology. 256(2). 223–227. 79 indexed citations
7.
Proba, Karl, Liming Ge, & Andreas Plückthun. (1995). Functional antibody single-chain fragments from the cytoplasm of Escherichia coli: influence of thioredoxin reductase (TrxB). Gene. 159(2). 203–207. 62 indexed citations
8.
Schulz, Georg E., Matthias Dreyer, Claudio Klein, et al.. (1992). Highly ordered crystals of channel-forming membrane proteins, of nucleoside-monophosphate kinases, of FAD-containing oxidoreductases and of sugar-processing enzymes and their mutants. Journal of Crystal Growth. 122(1-4). 385–392. 2 indexed citations
9.
Proba, Karl, Alfredo G. Tomasselli, Peter Nielsen, & Georg E. Schulz. (1987). The cDNA sequence encoding cytosolic adenylate kinase from baker's yeast (Saccharomyces cerevisiae). Nucleic Acids Research. 15(17). 7187–7187. 15 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026